Abstract
The humoral immune response and the antibody (Ab) neutralizing potential are important features for controlling dengue virus (DENV) infection and acquiring protective immunity against this pathogen. In this context, the plaque reduction neutralization test (PRNT) is currently the accepted approach to measuring DENV-neutralizing and protective profile of antibodies, and to assessing the im…